Mandate

VINGE ADVISES INDUSTRIFONDEN IN CONNECTION WITH THE FINANCING OF HASSELBLAD’S NEW CAMERAS

December 11, 2013

Industrifonden has provided financing to the camera maker, Hasselblad, in the form of a loan of approximately SEK 78 million with detachable options. The funds will be used for the launch of Hasselblad’s new series of cameras and for renewal of the existing range of cameras.

The new cameras will be available on the market shortly and the first two models, i.e. Lunar and Stellar, were launched recently. Since they are intended for amateur photographers, they are in a lower price and performance segment compared to Hasselblad’s traditional range of products, which are directed toward professional photographers.

Hasselblad’s current owner, the German-Swiss private equity firm, Vorndran Mannheims Capital, has made significant contributions in the form of renewal and greater degree of frequency of change of models in the existing H-system, where H5D was launched at the beginning of 2013.

Hasselblad’s production and R&D divisions are now based in Gothenburg where the company has doubled its production capacity and has recruited new personnel. Hasselblad is thus once again primarily a Swedish company.

Vinge’s team consisted of partner Johan Larsson and associate Lisa Antman.   

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025